Saves the questions and what to expect into your notes, next to the visit they belong to.
Keep this study
Lead
Amgen
Age
Any age
Sex
ALL
Healthy volunteers
Not accepted
You may be eligible if
\- Patients who have received a diagnosis of either of the following diseases and have received OTEZLA for the first time will be included in this survey.
Psoriasis vulgaris that is with an inadequate response to topical therapies
Psoriasis arthropathica
You may not be if
N/A
Clareo Health | Post-Marketing Surveillance Study of OTEZLA